News
Filter
-
LifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
-
ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
-
6 challenges in rare disease research and how we can overcome them
-
LifeArc Ventures: Six new investments, portfolio progress and an expanding investment team
-
Two influential life science leaders join LifeArc science team
-
NHS trial uses artificial intelligence to predict severe infections and transform lives of people living with chronic lung conditions
-
2023 wrapped: Our highlights from a successful year
-
LifeArc contributes to revitalisation of groundbreaking science education centre for children and young people
-
LifeArc announces £5 million drug repurposing programme for motor neuron disease
-
LifeArc-funded documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease
-
LifeArc helps fund new research institute to accelerate the search for a cure for MND
-
3 LifeArc Ventures’ portfolio companies celebrated in new report on most innovative life science businesses in UK
